首页|丹参酮ⅡA微球的研制与药剂学性质表征

丹参酮ⅡA微球的研制与药剂学性质表征

扫码查看
目的:通过正交试验优选制备丹参酮ⅡA微球的高分子材料和工艺条件.方法:采用乳化溶剂挥发法制备微球,以载药量、包封率及收率为主要评价指标,进行综合加权评分,确定最佳高分子材料和制备工艺,并用扫描电镜(SEM)、激光粒度仪、热重-差热分析(TG-DSC)、X射线衍射(XRD)进行表征.结果:采用左旋聚乳酸(PLLA)制备得到的丹参酮ⅡA微球的载药量和包封率显著高于其他高分子材料;最佳工艺制备的微球圆整,表面多孔,平均粒径为(96.95±1.7) μm,载药量为(30.43±0.04)%,包封率为(82.72±1.51)%,收率为(94.10±1.60)%.TG-DSC、XRD等结果表明,丹参酮ⅡA制备成微球后药物仍然有晶型存在.结论:乳化溶剂挥发法制备丹参酮ⅡA聚乳酸微球(TA-PLLA-MS)具有良好的药物负载作用,该方法简便易行,工艺稳定.
Preparation and Characterization of Pharmaceutical Properties of Tanshinone ⅡA Microspheres
Objective:To optimize the polymer material and process condition for preparation of tanshinone Ⅱ A microspheres by orthogonal design.Methods:The microspheres were prepared by emulsion solvent evaporation method.The optimum polymer material and preparation process were clarified by the comprehensive weighted score which was evaluated with the drug loading,encapsulation efficiency,and yield.The quality characterization of the tanshinone Ⅱ A microspheres were assayed by SEM,laser particle size analyzer,TG-DSC,and XRD.Results:The drug loading and encapsulation rate of microspheres prepared by PLLA was significantly higher than that of other polymer material.The surface of TA-PLLA-MS was round with porous structure,average particle size was (96.95 ± 1.7) μm,the drug loading was(30.43 ± 0.04)%,the entrapment efficiency was (82.72 ± 1.51)%,and the yield was (94.10 ± 1.60)%.The drug crystal form was still in the microspheres from the results of TG-DSC and XRD.Conclusion:The PLLA tanshinone Ⅱ A microspheres were prepared by emulsion solvent evaporation method which was simple,stable,and enough loaded drug.

MicrospheresPolymersTanshinone ⅡAOrthogonal test

朱娅芳、姜丰、吴朝花、周雪、沈祥春、陶玲

展开 >

贵州医科大学中药药剂教研室,贵州贵阳550025

贵州医科大学天然药物优效利用重点实验室,贵州贵阳550025

微球 高分子材料 丹参酮ⅡA 正交试验

贵州省国际科技合作计划贵州省科学技术基金贵阳市科技局现代药业计划贵州省中医药管理局课题

黔科合G字[2012]7041号黔科合J字[2013]2039号201220441QZYY2012-46

2016

中药材
国家食品药品监督管理局,中药材信息中心站

中药材

CSTPCD北大核心
影响因子:0.913
ISSN:1001-4454
年,卷(期):2016.39(1)
  • 5
  • 7